COVID-19 Testing Clinical Trial
Official title:
Determination of SARS-Cov-2 Virus in Central Nervous System
Coronavirus disease 2019 (COVID-19) is a highly infectious pandemic disease caused by SARS-CoV-2 virus. Central Nervous System (CNS) complications associated with COVID-19 might be secondary sequelae due to exuberant systemic innate-mediated hyper-inflammation, which may impair neurovascular endothelial function, disrupt blood brain barrier (BBB), activates CNS innate immune signaling pathways, and induces parainfectious autoimmunity, potentially contributing to the CNS manifestations. Although the predominant clinical manifestation of SARS-CoV-2 is characterized by dyspnea, unremitting fever and hypoxemic respiratory failure, neurologic manifestations do occur in most hospitalized SARS-CoV-2 patients and include non-specific encephalopathy, psychosis, meningitis/encephalitis, myelitis, cerebrovascular events, Guillain-Barre' syndrome, and cranial or peripheral neuropathies, such as anosmia and ageusia. To date, data about primary CNS involvement due to neurotropism and direct neuroinvasion are still lacking.
Determination of SARS-CoV-2 presence in central nervous system ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05473936 -
A CHW Intervention to Identify and Decrease Barriers to COVID 19 Testing & Vaccination
|
N/A | |
Enrolling by invitation |
NCT05178290 -
Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers
|
N/A | |
Completed |
NCT04926779 -
Study Utilizing BIOZEK COVID-19 Antigen Rapid Test
|
N/A | |
Completed |
NCT04758299 -
Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits
|
N/A | |
Active, not recruiting |
NCT05365750 -
COVID-19 Antibody and Reinfection Study
|
||
Recruiting |
NCT05139927 -
Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers
|
Phase 2 | |
Withdrawn |
NCT04696601 -
Rapid Screening for Olfactory Disorders in Covid-19 Infection
|
N/A | |
Completed |
NCT04913116 -
Generic Testing of Antigen Tests for COVID-19 in Denmark
|
||
Completed |
NCT04757298 -
Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
|
N/A |